• Education
  • Points
  •  Download App
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates

Other Services
 Education
 Points
  Download App
Country
singapore
malaysia
indonesia
thailand
philippines
vietnam
india
australia
korea
new zealand
Account
The MIMS logo.
  1. Medical News & Updates
  2. ...
    • Medical News & Updates
  3. List of News & Updates

News & Updates

Search
Showing Cardiology articles
Showing
MultidisciplinaryCardiologyDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
MultidisciplinaryCardiologyDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy

Filters

Specialty:
MultidisciplinaryCardiologyDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
Show Multimedia Only
Serum NT-proBNP could signal asymptomatic myocardial fibrosis
Serum NT-proBNP could signal asymptomatic myocardial fibrosis
10 Aug 2021

Elevated serum levels of the N-terminal pro-B-type peptide (NT-proBNP) seems to be an indicator of histopathologically proven myocardial fibrosis even among apparently healthy individuals, a recent study has found.

Serum NT-proBNP could signal asymptomatic myocardial fibrosis
10 Aug 2021
Exercise capacity low in AxSpA, translates to increased long-term CV risk
Exercise capacity low in AxSpA, translates to increased long-term CV risk
10 Aug 2021

Patients with axial spondyloarthritis (AxSpA) appear to have markedly low exercise capacity, which contributes to heightened 10-year cardiovascular (CV) event risk in this population, a study reports.

Exercise capacity low in AxSpA, translates to increased long-term CV risk
10 Aug 2021
  • 181
  • 182
The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Points
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty release/v3.13.0_2762.3
Copyright © 2026 MIMS Pte Ltd. All rights reserved. UAT
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.